ReviewClinical and translational allergy2022
Clinical review: The suggested management pathway for urticaria in primary care.
Review in Clinical and translational allergy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Article
- Specialist care improves diagnosis and treatment for patients with chronic spontaneous urticaria: A real-world survey.The journal of allergy and clinical immunology. Global · 2026Article
- Managing chronic spontaneous urticaria.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025Article
- Allergic-related skin diseases: Global disease burden from 1990 to 2021 and future trends.The World Allergy Organization journal · 2025Article
- Can urticaria severity be used as a biomarker for transition from acute to chronic urticaria?Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025Article
- A Patient Charter for Chronic Urticaria.Advances in therapy · 2024Article
- Clinical review: The suggested management pathway for urticaria in primary care.Clinical and translational allergy · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Urticaria is a common condition presenting both as acute and chronic disease within primary care. To those without specialist training it is poorly understood from the points of view of diagnosis and management. It causes a considerable disease burden to sufferers with marked impact on quality of life. Purpose of this review: The recent publication of the EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria guideline prompted us to take this excellent resource and re-configure its findings and recommendations to a non-specialist audience with particular reference to the needs of the primary care team.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.